文献速递主动脉疾病外周动脉疾病颈动脉与弓上血管

择期血管手术术前心脏评估与术后心肌梗死的长期趋势

Long-Term Trends in Preoperative Cardiac Evaluation and Myocardial Infarction after Elective Vascular Procedures.
PubMed 文献 · Ann Vasc Surg · 2020-09-22

基于VQI登记2003-2017年227,837例择期血管手术的回顾性队列研究显示,总体术后心肌梗死(POMI)率为1.3%,EVAR与膝下旁路(IIB)的POMI率显著下降且伴随心脏风险指数(CRI)降低和术前他汀使用增加,而CEA、oAAA、SIB及TEVAR无显著改善。

要点

  • EVAR的POMI率从2.0%降至0.7%(P=0.003),IIB从3.8%降至2.4%(P=0.003)。
  • CEA、oAAA、SIB及TEVAR的POMI率变化无统计学意义。
  • 仅EVAR和IIB的CRI降低,CEA、EVAR、IIB和oAAA的术前他汀使用显著增加(P<0.001)。

核心结论

  • 除TEVAR外,过去15年VQI登记中择期血管手术的POMI发生率保持不变或下降。
  • IIB和EVAR的POMI率下降与CRI降低及术前他汀使用增加相对应。
  • CEA和SIB的POMI率及CRI均无显著变化。

研究设计与样本

  • 回顾性队列研究,使用VQI登记2003至2017年的择期手术数据。
  • 共纳入227,837例择期手术,按3年一组分为5个时代进行亚组分析。
  • 手术类型包括CEA、TEVAR、EVAR、oAAA、SIB和IIB。

主要发现

  • 总体POMI率为1.3%。
  • CEA的POMI率从0.9%降至0.7%(P=0.21),EVAR从2.0%降至0.7%(P=0.003),oAAA从6.8%降至5.1%(P=0.12),IIB从3.8%降至2.4%(P=0.003)。
  • SIB的POMI率从3.06%降至2.95%(P=0.85,2009至2017年),TEVAR从2.40%升至2.56%(P=0.91,2009至2017年)。
  • 仅EVAR和IIB的CRI降低(P=0.059和P<0.001)。
  • CEA、EVAR、IIB和oAAA的术前他汀使用显著增加(P<0.001)。

临床怎么用

  • 对EVAR和IIB患者,术前他汀使用增加与POMI率下降相关,可考虑优化围术期他汀管理。
  • CEA、oAAA、SIB及TEVAR的POMI率未见显著改善,需关注这些手术的围术期心脏风险评估与优化。

局限性

  • POMI率下降的病因尚不明确,他汀使用、患者因素和手术选择可能是重要驱动因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vascular surgery has seen rapid increase in the use of less invasive endovascular therapies along with advancements in cardiac perioperative optimization in the past 2 decades. However, a recent American College of Surgeons National Surgical Quality Improvement Program database study found no improvement in postoperative myocardial infarction (POMI) over a 10-year period in high-risk procedures. The national Society for Vascular Surgery Vascular Quality Initiative (VQI) registry provides a more in-depth characterization of vascular surgery procedures. Here, we sought to evaluate long-term trends in POMI using VQI registry data for patients undergoing carotid endarterectomy (CEA), thoracic endovascular aortic repair (TEVAR), endovascular aortic repair (EVAR), open abdominal aortic aneurysm repair (oAAA), suprainguinal bypass (SIB), and infrainguinal bypass (IIB). METHODS: A retrospective cohort study was performed using data on elective procedures from 2003 to 2017. Procedures were subdivided by date of operation into 3-year era consecutive groups for subanalysis (2003-05, 2006-08, 2009-11, 2012-14, and 2015-17). The incidence of POMI, preoperative risk factors (including individual patient VQI cardiac risk index (CRI)), and demographics were determined over time. RESULTS: A total of 227,837 elective procedures were identified: CEA (n = 88,805, 39.0%), TEVAR (n = 7,494, 3.3%), EVAR (n = 34,376, 15.1%), oAAA (n = 7,568, 3.3%), SIB (n = 11,354, 5.0%), and IIB (n = 34,661, 15.2%). Across all procedures, the overall rate of POMI was 1.3%. POMI rates from 2003-05 to 2015-17 for CEA decreased from 0.9% to 0.7% (P = 0.21), EVAR from 2.0% to 0.7%, P = 0.003, oAAA from 6.8% to 5.1% (P = 0.12), and IIB from 3.8% to 2.4% (P = 0.003). SIB POMI decreased from 3.06% to 2.95%, P = 0.85 from 2009 to 17. While POMI after TEVAR increased from 2.40% to 2.56% from 2009 to 17, P = 0.91. Over these same time periods, only EVAR and IIB had a reduction in CRIs (P = 0.059 and P < 0.001, respectively). CEA, EVAR, IIB, and oAAA all showed a significant (P < 0.001) increase in preoperative statin use. CONCLUSIONS: Except for TEVAR, the incidence of POMI has remained unchanged or decreased over the past 15 years in VQI registries. Patients undergoing IIB and EVAR demonstrated decreases in POMI rates that correspond with a reduction in CRIs and increased preoperative statin use. CEA and SIB had no significant change in POMI rates nor CRIs. The etiology of decreased POMI rate is uncertain, but increasing statin use, patient-specific factors, and patient selection for procedures may be important drivers of this improvement.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Axley J, Novak Z, Blakeslee-Carter J, et al. Long-Term Trends in Preoperative Cardiac Evaluation and Myocardial Infarction after Elective Vascular Procedures. Ann Vasc Surg. 2020. PMID: 32976946. doi:10.1016/j.avsg.2020.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。